[go: up one dir, main page]

ZA200807879B - Use of bifidobacterium longum for the prevention and treatment of inflammation - Google Patents

Use of bifidobacterium longum for the prevention and treatment of inflammation

Info

Publication number
ZA200807879B
ZA200807879B ZA200807879A ZA200807879A ZA200807879B ZA 200807879 B ZA200807879 B ZA 200807879B ZA 200807879 A ZA200807879 A ZA 200807879A ZA 200807879 A ZA200807879 A ZA 200807879A ZA 200807879 B ZA200807879 B ZA 200807879B
Authority
ZA
South Africa
Prior art keywords
bifidobacterium longum
inflammation
prevention
treatment
baaa
Prior art date
Application number
ZA200807879A
Other languages
English (en)
Inventor
Annick Mercenier
Stephanie Blum-Sperisen
Florence Rochat
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of ZA200807879B publication Critical patent/ZA200807879B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ZA200807879A 2006-02-15 2008-09-12 Use of bifidobacterium longum for the prevention and treatment of inflammation ZA200807879B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06101690 2006-02-15

Publications (1)

Publication Number Publication Date
ZA200807879B true ZA200807879B (en) 2009-12-30

Family

ID=36636972

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200807879A ZA200807879B (en) 2006-02-15 2008-09-12 Use of bifidobacterium longum for the prevention and treatment of inflammation

Country Status (16)

Country Link
US (2) US8916145B2 (xx)
EP (1) EP1986669B1 (xx)
CN (1) CN101420965B (xx)
AT (1) ATE551063T1 (xx)
AU (1) AU2007216461B2 (xx)
BR (1) BRPI0707937A2 (xx)
CA (1) CA2642431A1 (xx)
ES (1) ES2381211T3 (xx)
MX (1) MX2008010422A (xx)
MY (1) MY148872A (xx)
PH (1) PH12012500739A1 (xx)
PL (1) PL1986669T3 (xx)
PT (1) PT1986669E (xx)
RU (1) RU2445362C2 (xx)
WO (1) WO2007093619A1 (xx)
ZA (1) ZA200807879B (xx)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
EP1885383B1 (en) 2005-05-31 2016-09-21 IAMS Europe B.V. Feline probiotic bifidobacteria
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
MX2009008166A (es) 2007-02-01 2009-08-12 Iams Company Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
CN101273736B (zh) * 2007-03-28 2012-08-08 北京弗蒙特生物技术有限公司 一种在常温下保持高活菌数的发酵乳的制备方法
EP2110028A1 (en) 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
EP2318513B1 (en) * 2008-07-11 2012-09-19 Chr. Hansen A/S New probiotic bifidobacterium longum
WO2010023178A1 (en) * 2008-08-28 2010-03-04 Chr. Hansen A/S Pharmaceuticals comprising a bacterial polysaccharide
US20100074870A1 (en) * 2008-09-19 2010-03-25 Bristol-Myers Squibb Company Probiotic infant products
CN102960447A (zh) * 2008-11-03 2013-03-13 雀巢产品技术援助有限公司 包含益生菌并改善睡眠模式的营养组合物
MX349705B (es) * 2008-11-11 2017-08-09 Alimentary Health Ltd Bifidobacterium longum.
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
MX338680B (es) 2009-05-11 2016-04-27 Nestec Sa Bifidobacterium longum ncc2705 (cncm i-2618) y padecimientos inmunes.
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
SG178167A1 (en) * 2009-08-18 2012-03-29 Nestec Sa A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
TR201807143T4 (tr) * 2009-08-25 2018-06-21 Nestec Sa Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar.
EP2308499A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Bifidobacterium longum ATCC BAA-999 (BL999) and weight control
PL2823822T3 (pl) * 2009-11-11 2017-09-29 Alimentary Health Limited Szczep Bifidobakterium
FI20096400A0 (fi) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö I
CN102971408B (zh) 2010-07-02 2016-03-02 宝洁公司 洗涤剂产品
RU2555042C2 (ru) 2010-07-02 2015-07-10 Дзе Проктер Энд Гэмбл Компани Способ доставки активнодействующего вещества
CA2803629C (en) 2010-07-02 2015-04-28 The Procter & Gamble Company Filaments comprising an active agent nonwoven webs and methods for making same
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
EP2449887B1 (en) * 2010-11-05 2016-01-06 Nestec S.A. Method for preparing pet food containing probiotic micro-organisms
EP2455092A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
ES3005933T3 (en) 2011-06-20 2025-03-17 Heinz Co Brands H J Llc Probiotic compositions and methods
PH12014500509B1 (en) * 2011-10-18 2019-02-13 Nestec Sa Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
CN103820357A (zh) * 2013-12-30 2014-05-28 上海交大昂立股份有限公司 一株长双歧杆菌及其防治食物过敏的功能
CN105816484A (zh) * 2015-01-07 2016-08-03 东宇生物科技股份有限公司 用于腹膜透析病患预防腹膜炎并减少肾功能恶化的组合物
WO2017037089A1 (en) * 2015-08-31 2017-03-09 Nestec S.A. Methods and compositions using bifidobacterium longum to treat or prevent depressive symptoms
WO2017102816A1 (en) * 2015-12-14 2017-06-22 Metabogen Ab Treatment of intrahepatic cholestasis and related liver diseases
EP3573722B1 (en) 2017-01-27 2022-02-23 The Procter & Gamble Company Compositions in the form of dissolvable solid structures comprising effervescent agglomerated particles
RU2752157C2 (ru) * 2017-01-31 2021-07-23 Юниверсити-Индастри Кооперейшн Груп Оф Кюн Хее Юниверсити Новые молочнокислые бактерии и их применение
MX386124B (es) 2017-05-16 2025-03-18 Procter & Gamble Composiciones acondicionadoras para el cuidado del cabello en la forma de estructuras sólidas solubles.
US11590181B2 (en) 2017-12-29 2023-02-28 Societe Des Produits Nestle S.A. Serpin production
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
AU2019353693A1 (en) * 2018-10-02 2021-04-01 Société des Produits Nestlé S.A. Probiotic combination for treatment of inflammatory-related gastrointestinal disorders
AU2019410036A1 (en) * 2018-12-21 2021-06-03 Société des Produits Nestlé S.A. Probiotic combination for treatment of allergic disorders
BR112021023244A2 (pt) 2019-06-28 2022-01-04 Procter & Gamble Artigos fibrosos sólidos dissolvíveis contendo tensoativos aniônicos
BR112021024311A2 (pt) * 2019-07-01 2022-01-11 Nestle Sa Produção de serpina
BR112021025362A2 (pt) * 2019-07-01 2022-02-01 Nestle Sa Produção de serpina
CN115867357A (zh) 2020-07-31 2023-03-28 宝洁公司 用于毛发护理的含有球粒的水溶性纤维小袋
KR102343938B1 (ko) * 2020-09-02 2021-12-28 주식회사 비피도 재조합 비피도박테리움 비피덤 bgn4를 포함하는 염증 개선용 조성물
CN112159784A (zh) * 2020-10-29 2021-01-01 佛山市朗芯生物科技有限公司 长双歧杆菌nx-4及其在制备治疗和/或预防过敏性疾病药物中的应用
CH718355A2 (fr) * 2021-02-16 2022-08-31 Nestle Sa Composition et kit pour soulager les symptômes de l'allergie respiratoire.
CN117881380A (zh) 2021-08-30 2024-04-12 宝洁公司 包含第一聚合结构剂和第二聚合结构剂的可溶性固体结构
CN114574390B (zh) * 2022-03-09 2024-03-01 江南大学 一株缓解结肠炎的长双歧杆菌婴儿亚种及应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
DK0577903T3 (da) 1992-07-06 1998-04-06 Nestle Sa Antigastritisk middel
EP0577904B1 (fr) 1992-07-06 1997-05-14 Societe Des Produits Nestle S.A. Bactérie lactique
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
ATE206873T1 (de) 1997-01-09 2001-11-15 Nestle Sa Probiotik enthaltendes getreideprodukt
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
MXPA03007802A (es) * 2001-03-09 2003-12-08 Nestle Sa Composicion que mejora las deficiencias fisiologicas relacionadas con la edad y que incrementa la longevidad.
RU2210592C1 (ru) * 2001-12-27 2003-08-20 Российский государственный медицинский университет ШТАММ БАКТЕРИЙ Bifidobacterium longum 58B ДЛЯ ПРИГОТОВЛЕНИЯ БИОЛОГИЧЕСКИ АКТИВНЫХ ДОБАВОК, РЕГУЛИРУЮЩИХ МИКРОФЛОРУ КИШЕЧНИКА У ДЕТЕЙ РАННЕГО ВОЗРАСТА
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
AU2003303894A1 (en) * 2003-01-30 2004-08-30 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
TWI324068B (en) * 2003-03-13 2010-05-01 Kirin Holdings Kk Antiallergic composition
ES2326481T3 (es) * 2003-06-23 2009-10-13 Nestec S.A. Formula para recien nacidos o formula de continuacion.
PL1638416T3 (pl) * 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej

Also Published As

Publication number Publication date
RU2008136876A (ru) 2010-03-20
ES2381211T3 (es) 2012-05-24
CA2642431A1 (en) 2007-08-23
AU2007216461A1 (en) 2007-08-23
EP1986669A1 (en) 2008-11-05
PT1986669E (pt) 2012-05-15
AU2007216461B2 (en) 2012-08-30
US9456630B2 (en) 2016-10-04
CN101420965A (zh) 2009-04-29
RU2445362C2 (ru) 2012-03-20
US8916145B2 (en) 2014-12-23
PL1986669T3 (pl) 2012-09-28
MY148872A (en) 2013-06-14
ATE551063T1 (de) 2012-04-15
US20120201785A1 (en) 2012-08-09
EP1986669B1 (en) 2012-03-28
BRPI0707937A2 (pt) 2011-05-10
CN101420965B (zh) 2013-08-07
PH12012500739A1 (en) 2013-06-17
US20090274661A1 (en) 2009-11-05
WO2007093619A1 (en) 2007-08-23
MX2008010422A (es) 2008-10-27

Similar Documents

Publication Publication Date Title
ZA200807879B (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
AU2008232453A8 (en) Methods and compositions for reduction of side effects of therapeutic treatments
UA108198C2 (xx) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
IL201479A (en) Use of tapentadol for the preparation of pain medication
MX2009009318A (es) Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
UA100551C2 (xx) Синбіотична суміш$синбиотическая смесь
MX2012002402A (es) Bifidobacterium longum y trastornos gastrointestinales funcionales.
EP2099449A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF DISEASES THAT COME WITH IMPOTENCE
MX343358B (es) Tabletas de acetato de ulipristal.
MX2011011950A (es) Composiciones de dexmedetomidina sublinguales y metodos de uso de las mismas.
WO2007100561A3 (en) Use of dha and ara in the preparation of a composition for preventing or treating obesity
WO2009080800A3 (en) Method for decreasing abdominal girth by administering a bifidobacterium bacteria
WO2009068708A8 (es) Composición farmacéutica de liberación sostenida de somatostatina o un análogo suyo
MY158310A (en) Prevention and treatment of allergic diarrhoea
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
WO2008090209A3 (en) Use of glucopyranosyloxy- pyrazoles for preventing and treating neurodegenerative disorders
SG169346A1 (en) Use of yeast flakes for treating and/or preventing hyperinsulinemia
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
IL194353A0 (en) Lysobactin amides
WO2008018111A3 (en) Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections
WO2010150098A3 (en) Use of quingolide in the treatment of endometriosis, pain and cancer
EA200801890A1 (ru) Средство для лечения шума в ушах
WO2007041388A3 (en) Prevention and treatment of hearing disorders
MX2010003615A (es) Tratamiento de desordenes neurologicos.